Hjem › Diffust stort B-cellelymfom › Wisconsin › Milwaukee
Kliniske studier for Diffust stort B-cellelymfom i Milwaukee, WI
16 studier for Diffust stort B-cellelymfom søker deltakere på steder i og rundt Milwaukee (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruttererObservasjonsstudie
- Children's Hospital of Wisconsin, Milwaukee
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
RekruttererFase 2
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11 mi unna
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mi unna
- og 3 flere
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
RekruttererFase 2
- Medical College of Wisconsin ( Site 0103), Milwaukee
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RekruttererFase 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekruttererFase 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of ARC-02 in B-cell NHL
RekruttererFase 1
- Froedtert & Medical College of Wisconsin, Milwaukee
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekruttererFase 1/2
- Medical College of Wisconsin, Milwaukee
Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma
RekruttererFase 2
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
RekruttererFase 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
RekruttererObservasjonsstudie
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
DALY II USA/ MB-CART2019.1 for DLBCL
RekruttererFase 2
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RekruttererFase 1
- Medical College of Wisconsin, Milwaukee
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
RekruttererFase 1/2
- Medical College of Wisconsin and Froedtert Hospital, Milwaukee
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
RekruttererFase 2
- Medical College of Wisconsin, Milwaukee
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mi unna
Long-term Follow-up Study of Patients Receiving CAR-T Cells
RekruttererObservasjonsstudie
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
RekruttererFase 2
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- og 4 flere
Diffust stort B-cellelymfom-studier i andre byer
- New York City, NY21 studier
- Baldwin Park, CA19 studier
- Chicago, IL18 studier
- Houston, TX17 studier
- Los Angeles, CA17 studier
- Boston, MA16 studier
- Nashville, TN15 studier
- Portland, OR15 studier
- Philadelphia, PA15 studier
- Durham, NC14 studier
- Dallas, TX13 studier
- Seattle, WA12 studier
Andre studier i Milwaukee
- Brystkreft23 studier
- Ikke-småcellet lungekreft22 studier
- Kreft (alle typer)22 studier
- Lungekreft21 studier
- Multipelt myelom21 studier
- Prostatakreft20 studier
- Follikulært lymfom19 studier
- Pankreaskreft18 studier
- Non-Hodgkins lymfom18 studier
- Eggstokkreft17 studier
- Akut myelogen leukemi17 studier
- Burkitts lymfom16 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.